Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study (TSAP)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
VitrOmics BV
Information provided by:
VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01190241
First received: August 26, 2010
Last updated: March 19, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)